In contrast, the group that experienced MS and received isorhamnetin treatment demonstrated a notable increase in Sirt1 mRNA levels compared to those treated with saline alone (F(1, 28) = 12.35, p = 0.0011). This evidence concerns the gene SIRT1 and myeloid sarcoma.